Stay updated on APR-246+Azacitidine Post-AlloSCT in TP53 Mut AML/MDS Clinical Trial

Sign up to get notified when there's something new on the APR-246+Azacitidine Post-AlloSCT in TP53 Mut AML/MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the APR-246+Azacitidine Post-AlloSCT in TP53 Mut AML/MDS Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The displayed ClinicalTrials.gov site revision changes from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-01T15:42:47.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    0.7%
    Check dated 2026-10-25T16:09:13.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T16:10:48.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-11T16:30:24.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The history now includes a new revision entry for v3.7.0, indicating a recent update to the study record; the older revision v3.6.6 has been removed from the history list.
    Difference
    0.1%
    Check dated 2026-09-20T20:07:56.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    There are no additions or deletions listed for the study record history, so the page content remains in its current state.
    Difference
    0.1%
    Check dated 2026-09-06T18:43:24.000Z thumbnail image

Stay in the know with updates to APR-246+Azacitidine Post-AlloSCT in TP53 Mut AML/MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the APR-246+Azacitidine Post-AlloSCT in TP53 Mut AML/MDS Clinical Trial page.